141 related articles for article (PubMed ID: 23047478)
1. B-lineage transcription factors and cooperating gene lesions required for leukemia development.
Tijchon E; Havinga J; van Leeuwen FN; Scheijen B
Leukemia; 2013 Mar; 27(3):541-52. PubMed ID: 23047478
[TBL] [Abstract][Full Text] [Related]
2. STAT5 in B cell development and leukemia.
Malin S; McManus S; Busslinger M
Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
[TBL] [Abstract][Full Text] [Related]
3. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.
Kuiper RP; Schoenmakers EF; van Reijmersdal SV; Hehir-Kwa JY; van Kessel AG; van Leeuwen FN; Hoogerbrugge PM
Leukemia; 2007 Jun; 21(6):1258-66. PubMed ID: 17443227
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
Mullighan CG; Goorha S; Radtke I; Miller CB; Coustan-Smith E; Dalton JD; Girtman K; Mathew S; Ma J; Pounds SB; Su X; Pui CH; Relling MV; Evans WE; Shurtleff SA; Downing JR
Nature; 2007 Apr; 446(7137):758-64. PubMed ID: 17344859
[TBL] [Abstract][Full Text] [Related]
5. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of pre-B cell development and leukemia prevention.
Pang SH; Carotta S; Nutt SL
Curr Top Microbiol Immunol; 2014; 381():189-213. PubMed ID: 24831348
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional regulation of B cell lineage commitment.
Nutt SL; Kee BL
Immunity; 2007 Jun; 26(6):715-25. PubMed ID: 17582344
[TBL] [Abstract][Full Text] [Related]
8. Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).
Kawamura M; Taki T; Kaku H; Ohki K; Hayashi Y
Genes Chromosomes Cancer; 2015 Jul; 54(7):401-8. PubMed ID: 25951811
[TBL] [Abstract][Full Text] [Related]
9. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
10. Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.
Xu LS; Sokalski KM; Hotke K; Christie DA; Zarnett O; Piskorz J; Thillainadesan G; Torchia J; DeKoter RP
J Immunol; 2012 Oct; 189(7):3347-54. PubMed ID: 22956576
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of transcription factor deregulation in lymphoid cell transformation.
O'Neil J; Look AT
Oncogene; 2007 Oct; 26(47):6838-49. PubMed ID: 17934490
[TBL] [Abstract][Full Text] [Related]
12. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
[TBL] [Abstract][Full Text] [Related]
13. The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation.
Holroyd A; Cross NC; Macdonald DH
Leuk Res; 2011 Oct; 35(10):1279-85. PubMed ID: 21722956
[TBL] [Abstract][Full Text] [Related]
14. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
[TBL] [Abstract][Full Text] [Related]
15. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
16. New mechanisms of AML1 gene alteration in hematological malignancies.
Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor expression in B-cell precursor-leukemia cell lines: preferential expression of T-bet.
Harashima A; Matsuo Y; Drexler HG; Okochi A; Motoda R; Tanimoto M; Orita K
Leuk Res; 2005 Jul; 29(7):841-8. PubMed ID: 15927679
[TBL] [Abstract][Full Text] [Related]
18. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
Naghashpour M; Lancet J; Moscinski L; Zhang L
Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of human leukemias: new insights into therapy.
Gilliland DG
Semin Hematol; 2002 Oct; 39(4 Suppl 3):6-11. PubMed ID: 12447846
[TBL] [Abstract][Full Text] [Related]
20. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines.
Verschuren MC; Comans-Bitter WM; Kapteijn CA; Mason DY; Brouns GS; Borst J; Drexler HG; van Dongen JJ
Leukemia; 1993 Dec; 7(12):1939-47. PubMed ID: 8255092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
